Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Reporter of Georgia.
Press releases published on May 8, 2025
SplashBI Supercharges Executive Team with CFO & CAIO Appointments to Power the Future of Enterprise Analytics
EIN Presswire
·
May 8, 2025
DULUTH, GA, UNITED STATES, May 8, 2025 /EINPresswire.com/ -- SplashBI, the AI-powered analytics platform delivering conversational insights, unified reporting, and advanced analytics, today announced two high-impact additions to its executive team. Dan …
The Preventive Measures Foundation Hosts the 9th Annual 'A Million Steps to Mental Health Awareness Walk'
EIN Presswire
·
May 8, 2025
Step up for healing: Join TPMF’s 9th Annual Mental Health Walk to support youth, recovery, and community wellness in Covington, GA. COVINGTON, GA, UNITED STATES, May 8, 2025 /EINPresswire.com/ -- On Saturday, May 17, The Preventive Measures Foundation ( …
Femasys Announces Financial Results for Quarter Ended March 31, 2025, and Provides Corporate Update
GlobeNewswire
·
May 8, 2025
-- Company delivers on mission to transform women’s health with innovative solutions, including FemaSeed® for first-line infertility treatment and FemBloc® non-surgical permanent birth control (full system approval pending in Europe) -- ATLANTA, May 08, …
DLH to Continue Providing R&D and Advanced Technology Services to the Telemedicine and Advanced Technology Research Center
GlobeNewswire
·
May 8, 2025
ATLANTA, May 08, 2025 (GLOBE NEWSWIRE) -- DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading provider of science research and development, systems engineering and integration, and digital transformation and cyber security, today …
Dogwood Therapeutics Announces First Quarter 2025 Financial Results
GlobeNewswire
·
May 8, 2025
- Dogwood Therapeutics, Inc. commenced dosing of patients in the Halneuron® Chemotherapy Induced Neuropathic Pain Phase 2b Study - - Halneuron® Chemotherapy Induced Neuropathic Pain Phase 2b study interim data readout is expected in Q4 2025 - - Cash on …
Alzamend Neuro Announces Reverse Stock Split
GlobeNewswire
·
May 8, 2025
ATLANTA, May 08, 2025 (GLOBE NEWSWIRE) -- Alzamend Neuro, Inc. (Nasdaq: ALZN) (“Alzamend” or the “Company”), a clinical-stage biopharmaceutical company focused on developing novel products for the treatment of Alzheimer’s disease (“Alzheimer’s”), bipolar …
Aveanna Healthcare Holdings Announces First Quarter Financial Results and Revised 2025 Outlook
GlobeNewswire
·
May 8, 2025
First Quarter Revenue was $559.2 million, a 14.0% increase over the prior year period Gross margin increased 25.9% to $183.6 million compared to Q1 2024 First Quarter Net income was $5.2 million compared to net loss of $11.2 million for the comparable …